Rolfe Winkler
Wall Street Journal reporter Rolfe Winkler is now covering health technology.
His new beat comes after a six-month assignment on the newspaper’s health team, where he wrote about topics such as digital contact tracing, vaccine trials, and Palantir’s software to distribute the vaccine. His previous primary focus was venture capital and startups.
Winkler has had a number of scoops on this beat in the past that drove his interest. One was Elon Musk’s Neuralink while another was Outcome Health, about which he led a multi-month investigation, discovered it was misleading customers. Investors sued and the government has already secured three felony guilty pleas and indicted three other executives.
Winkler has been at the Journal since July 2010, first working on the “Heard on the Street” column.
He previously was a columnist for Reuters and also worked as an analyst for a hedge fund.
Former Business Insider executive editor Rebecca Harrington has been hired by Dynamo to be its…
Bloomberg Television has hired Brenda Kerubo as a desk producer in London. She will be covering Europe's…
In a meeting at CNBC headquarters Thursday afternoon, incoming boss Mark Lazarus presented a bullish…
Ritika Gupta, the BBC's North American business correspondent, was interviewed by Global Woman magazine about…
Rest of World has hired Kinling Lo as a China reporter. Lo was previously a…
Bloomberg News saw strong unique visitor growth to its website in October, passing Fox Business…